Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07122492 · ClinicalTrials.gov registry record · NA
A Targeted Electronic Health Approach to Reduce Fear of Recurrence in Breast Cancer Survivors (FoRtitude)
A NA study, sponsored by Eastern Cooperative Oncology Group.
- Not yet
- Registry status
- NA
- Development phase
- 800
- Enrollment target
NCT07122492 is a NA study that has not yet begun recruiting, run by Eastern Cooperative Oncology Group. The registered enrollment target is 800 participants.
The verdict
NCT07122492, a NA study, has not yet begun recruiting, sponsored by Eastern Cooperative Oncology Group.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
Study Summary
The goal of this study is to determine if the intervention or if general information about being a breast cancer survivor can help Breast Cancer Survivors reduce their fear of recurrence. The main question it aims to answer are: Can the FoRtitude intervention lower the fear of recurrence for Breast Cancer Survivors? Participants will: Answer questions about their fear of recurrence. Be randomized to 1 of the 3 following options: (1) a weblink to access an eHealth intervention which includes a website and an optional interactive text-messaging feature, (2) a weblink to a non-interactive website that will include links to external websites with general information that may be helpful for Breast Cancer Survivors, or (3) you will need to talk with your oncology team about your concerns about recurrence or seek psychosocial care in the community. Be asked to fill out questionnaires 5 times for up to 18 months.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL FoRtitude 2.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2029-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07122492
The ClinicalTrials.gov registry entry for NCT07122492 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT07122492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07122492 about?
NCT07122492 is a clinical study titled "A Targeted Electronic Health Approach to Reduce Fear of Recurrence in Breast Cancer Survivors (FoRtitude)". The goal of this study is to determine if the intervention or if general information about being a breast cancer survivor can help Breast Cancer Survivors reduce their fear of recurrence. The main question it aims to answer are: Can the FoRtitude intervention lower the fear of recurrence for Breast...
What is the current status of trial NCT07122492?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2025-09-01. Estimated completion is 2029-09-01.
What interventions are being tested in trial NCT07122492?
The interventions under investigation include: Attention Control (BEHAVIORAL), FoRtitude 2.0 (BEHAVIORAL).
Who is sponsoring clinical trial NCT07122492?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.